耐斯系統 NICE 深 滬
等待開盤 05-23 09:30:00 美东时间
94.46
-0.890
-0.93%
華盛通- 最 高97.80
- 今 開95.50
- 成交量 46.28万股
- 最 低 94.33
- 昨 收 95.35
- 總市值 561.13万
- 52周最高 180.61
- 市盈率 靜 9.70
- 換手率 0.78%
- 52周最低 84.3825
- 委 比 91.30%
- 總股本 5.94万
- 歷史最高 319.88
- 量 比 0.77
- 振 幅 3.64%
- 歷史最低 25.855
- 每 手 1
- 風險率 23.33%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
Citizens Maintains Market Outperform on NICE, Lowers Price Target to $170
Citizens analyst Patrick Walravens maintains NICE (NASDAQ:NICE) with a Market Outperform and lowers the price target from $200 to $170.
05-08 00:44
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
NICE shares are trading lower. The company reported Q1 financial results.
NICE shares are trading lower. The company reported Q1 financial results.
05-06 22:42
Transcript: NICE Q1 2026 Earnings Conference Call
NICE (NASDAQ:NICE) released first-quarter financial results and hosted an earni...
05-06 21:47
What's Going On With NICE Stock Wednesday?
NICE beats Q1 2026 expectations with $2.64 EPS and $768.6M in sales. Cloud revenue up 14.6% as AI momentum drives growth.
05-06 19:15
NICE Sees Q2 Adj EPS $2.60-$2.70 vs $2.65 Est; Sees Sales $761.000M-$771.000M vs $780.640M Est
NICE (NASDAQ:NICE) is looking for Q2 Adj EPS of $2.60-$2.70 vs $2.65 analyst estimate. sees sales of $761.000 million-$771.000 million vs $780.640 million analyst estimate.
05-06 17:34
NICE Q1 Adj. EPS $2.64 Beats $2.52 Estimate, Sales $768.617M Beat $764.239M Estimate
NICE (NASDAQ:NICE) reported quarterly earnings of $2.64 per share which beat the analyst consensus estimate of $2.52 by 4.76 percent. This is a 8.01 percent decrease over earnings of $2.87 per share from the same period
05-06 17:32
